ATE227725T1 - Verfahren zur herstellung von galanthanin - Google Patents

Verfahren zur herstellung von galanthanin

Info

Publication number
ATE227725T1
ATE227725T1 AT97900276T AT97900276T ATE227725T1 AT E227725 T1 ATE227725 T1 AT E227725T1 AT 97900276 T AT97900276 T AT 97900276T AT 97900276 T AT97900276 T AT 97900276T AT E227725 T1 ATE227725 T1 AT E227725T1
Authority
AT
Austria
Prior art keywords
pct
galanthamine
date jul
galanthanin
producing
Prior art date
Application number
AT97900276T
Other languages
English (en)
Inventor
Peter David Tiffin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE227725T1 publication Critical patent/ATE227725T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Glass Compositions (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97900276T 1996-01-04 1997-01-06 Verfahren zur herstellung von galanthanin ATE227725T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600080.7A GB9600080D0 (en) 1996-01-04 1996-01-04 Resolution process
PCT/GB1997/000023 WO1997025330A1 (en) 1996-01-04 1997-01-06 Process for the preparation of galanthamine

Publications (1)

Publication Number Publication Date
ATE227725T1 true ATE227725T1 (de) 2002-11-15

Family

ID=10786571

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900276T ATE227725T1 (de) 1996-01-04 1997-01-06 Verfahren zur herstellung von galanthanin

Country Status (12)

Country Link
US (1) US6087495A (de)
EP (1) EP0880525B1 (de)
AT (1) ATE227725T1 (de)
AU (1) AU700997B2 (de)
CA (1) CA2239814C (de)
DE (1) DE69717076T2 (de)
DK (1) DK0880525T3 (de)
ES (1) ES2186862T3 (de)
GB (1) GB9600080D0 (de)
PT (1) PT880525E (de)
WO (1) WO1997025330A1 (de)
ZA (1) ZA9781B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2310926C (en) * 2000-04-03 2002-10-15 Janssen Pharmaceutica N.V. A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
US20050142193A1 (en) * 2003-12-31 2005-06-30 Lijuan Tang Galantamine formulations
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine
WO2006013546A2 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Process for the preparation of pure galantamine
CN102050826B (zh) * 2010-12-21 2012-11-14 浙江工业大学 一种分离加兰他敏的方法
KR101834104B1 (ko) 2014-01-15 2018-03-02 엑손모빌 케미칼 패턴츠 인코포레이티드 프로필렌계 내충격성 공중합체
WO2019050582A1 (en) 2017-09-11 2019-03-14 Exxonmobil Chemical Patents Inc. ARTICLES COMPRISING ANTICHOC POLYPROPYLENE COPOLYMERS AND METHODS OF MAKING SAME
CN116157429A (zh) 2020-07-17 2023-05-23 埃克森美孚化学专利公司 具有低水平挥发性有机化合物的聚合物和制备此类聚合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
AU1386797A (en) 1997-08-01
ZA9781B (en) 1998-01-06
CA2239814A1 (en) 1997-07-17
DE69717076T2 (de) 2003-07-17
DE69717076D1 (de) 2002-12-19
EP0880525B1 (de) 2002-11-13
DK0880525T3 (da) 2003-03-03
CA2239814C (en) 2006-08-29
ES2186862T3 (es) 2003-05-16
PT880525E (pt) 2003-03-31
EP0880525A1 (de) 1998-12-02
GB9600080D0 (en) 1996-03-06
US6087495A (en) 2000-07-11
AU700997B2 (en) 1999-01-14
WO1997025330A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
ATE234829T1 (de) Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden
ATE226940T1 (de) Verfahren zur herstellung von d-threo-(r,r)- methylphenidat und recycling nicht erwünschter enantiomere durch epimerisierung
DE69115883D1 (de) Verfahren zur herstellung von salzen von aminocarbonsäuren
ATE267812T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
DE69717076D1 (de) Verfahren zur herstellung von galanthanin
ATE216365T1 (de) Verfahren zur racematspaltung
ATE218131T1 (de) Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
DE59608718D1 (de) Verfahren zur herstellung von substituierten 4,4'-diaminostilben-2,2'-disulfonsäuresalzen
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE3863378D1 (de) Verfahren zur herstellung von koks hoher qualitaet.
SE9601600D0 (sv) Improved process
DE69713163D1 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
ATE411281T1 (de) Verfahren zur herstellung von s-aryl-cystein
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
ATE258161T1 (de) Verfahren zur herstellung von chiralen aminosäuren
DE69414586D1 (de) Verfahren zur herstellung von indolizinderivaten
ATE268753T1 (de) Verfahren zur herstellung von 24(s)- hydroxyvitamin d2
ATE269863T1 (de) Verfahren zur herstellung von granisetron
ATE207461T1 (de) Verfahren zur herstellung einer aktivierten aminosäure
DE69510227D1 (de) Verfahren zur herstellung von fluorierten heterozyklischen verbindungen
ATE184006T1 (de) Verfahren zur herstellung von loracarbef- monohydrat
ATE215603T1 (de) Verfahren zur herstellung von optisch aktivem 2- substituiertem tetrahydropyran-4-on

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0880525

Country of ref document: EP